Skip to main content
. 2021 Jul 28;27(19):5195–5212. doi: 10.1158/1078-0432.CCR-21-1059

Figure 6.

Figure 6. Clinical Case 6—Use of MRD in a patient with relapsed refractory myeloma.

Clinical Case 6—Use of MRD in a patient with relapsed refractory myeloma.